Cargando…

Endothelial dysfunction in patients with lone atrial fibrillation

BACKGROUND: Atrial fibrillation (AF) is the most common tachyarrhythmia in patients with cardiovascular diseases (CVDs) and may have significant complications such as stroke. The present study aims to evaluate endothelial dysfunction in patients with lone atrial fibrillation (LAF) through flow-media...

Descripción completa

Detalles Bibliográficos
Autores principales: Heshmat-Ghahdarijani, Kiyan, Jangjoo, Shahrzad, Amirpour, Afshin, Najafian, Jamshid, Khosravi, Alireza, Heidarpour, Maryam, Hekmat, Mostafa, Shafie, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172232/
https://www.ncbi.nlm.nih.gov/pubmed/34122581
http://dx.doi.org/10.22122/arya.v16i6.2095
_version_ 1783702501644566528
author Heshmat-Ghahdarijani, Kiyan
Jangjoo, Shahrzad
Amirpour, Afshin
Najafian, Jamshid
Khosravi, Alireza
Heidarpour, Maryam
Hekmat, Mostafa
Shafie, Davood
author_facet Heshmat-Ghahdarijani, Kiyan
Jangjoo, Shahrzad
Amirpour, Afshin
Najafian, Jamshid
Khosravi, Alireza
Heidarpour, Maryam
Hekmat, Mostafa
Shafie, Davood
author_sort Heshmat-Ghahdarijani, Kiyan
collection PubMed
description BACKGROUND: Atrial fibrillation (AF) is the most common tachyarrhythmia in patients with cardiovascular diseases (CVDs) and may have significant complications such as stroke. The present study aims to evaluate endothelial dysfunction in patients with lone atrial fibrillation (LAF) through flow-mediated dilation (FMD) in the brachial artery, as a non-invasive method for evaluating functional and structural markers of endothelial dysfunction. METHODS: In this case-control study, 43 patients with LAF were selected. 51 age and sex-matched healthy individuals were selected as the control group. The brachial artery diameter of the subjects in both groups was measured through FMD. The obtained data were analyzed by SPSS software. RESULTS: Patients with LAF and healthy subjects did not have any difference in terms of gender, heart rate (HR), and systolic blood pressure (SBP) (P > 0.05 for all). FMD of the patients with AF was significantly lower (P = 0.04) than FMD of the healthy controls. CONCLUSION: Our findings showed that LAF was associated with systemic endothelial dysfunction. AF plays an important and independent role in reducing FMD.
format Online
Article
Text
id pubmed-8172232
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-81722322021-06-10 Endothelial dysfunction in patients with lone atrial fibrillation Heshmat-Ghahdarijani, Kiyan Jangjoo, Shahrzad Amirpour, Afshin Najafian, Jamshid Khosravi, Alireza Heidarpour, Maryam Hekmat, Mostafa Shafie, Davood ARYA Atheroscler Original Article BACKGROUND: Atrial fibrillation (AF) is the most common tachyarrhythmia in patients with cardiovascular diseases (CVDs) and may have significant complications such as stroke. The present study aims to evaluate endothelial dysfunction in patients with lone atrial fibrillation (LAF) through flow-mediated dilation (FMD) in the brachial artery, as a non-invasive method for evaluating functional and structural markers of endothelial dysfunction. METHODS: In this case-control study, 43 patients with LAF were selected. 51 age and sex-matched healthy individuals were selected as the control group. The brachial artery diameter of the subjects in both groups was measured through FMD. The obtained data were analyzed by SPSS software. RESULTS: Patients with LAF and healthy subjects did not have any difference in terms of gender, heart rate (HR), and systolic blood pressure (SBP) (P > 0.05 for all). FMD of the patients with AF was significantly lower (P = 0.04) than FMD of the healthy controls. CONCLUSION: Our findings showed that LAF was associated with systemic endothelial dysfunction. AF plays an important and independent role in reducing FMD. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2020-11 /pmc/articles/PMC8172232/ /pubmed/34122581 http://dx.doi.org/10.22122/arya.v16i6.2095 Text en © 2020 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences https://creativecommons.org/licenses/by-nc/3.0/This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Heshmat-Ghahdarijani, Kiyan
Jangjoo, Shahrzad
Amirpour, Afshin
Najafian, Jamshid
Khosravi, Alireza
Heidarpour, Maryam
Hekmat, Mostafa
Shafie, Davood
Endothelial dysfunction in patients with lone atrial fibrillation
title Endothelial dysfunction in patients with lone atrial fibrillation
title_full Endothelial dysfunction in patients with lone atrial fibrillation
title_fullStr Endothelial dysfunction in patients with lone atrial fibrillation
title_full_unstemmed Endothelial dysfunction in patients with lone atrial fibrillation
title_short Endothelial dysfunction in patients with lone atrial fibrillation
title_sort endothelial dysfunction in patients with lone atrial fibrillation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172232/
https://www.ncbi.nlm.nih.gov/pubmed/34122581
http://dx.doi.org/10.22122/arya.v16i6.2095
work_keys_str_mv AT heshmatghahdarijanikiyan endothelialdysfunctioninpatientswithloneatrialfibrillation
AT jangjooshahrzad endothelialdysfunctioninpatientswithloneatrialfibrillation
AT amirpourafshin endothelialdysfunctioninpatientswithloneatrialfibrillation
AT najafianjamshid endothelialdysfunctioninpatientswithloneatrialfibrillation
AT khosravialireza endothelialdysfunctioninpatientswithloneatrialfibrillation
AT heidarpourmaryam endothelialdysfunctioninpatientswithloneatrialfibrillation
AT hekmatmostafa endothelialdysfunctioninpatientswithloneatrialfibrillation
AT shafiedavood endothelialdysfunctioninpatientswithloneatrialfibrillation